Insider Activity and Operational Updates at Nexgel Inc.: Analysis of Executive Stock Sales Amid Company Milestones
Nexgel CEO Adam R. Levy executed three separate transactions in late May, selling a total of 13,000 shares of the company's common stock for approximately $7,834. The report details these insider sales alongside recent corporate developments, including Q1 2026 financial results and promising clinical study outcomes for the firm's hydrogel patch.